{
    "title": "113_hr5318",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Label and Transport Tissues Safely \nAct of 2014'' or as the ``LATTS Act of 2014''.\n\nSEC. 2. IN GENERAL.\n\n    (a) Non-Transplant Tissue Bank License.--\n            (1) Prohibition.--No person may introduce or deliver for \n        introduction into interstate commerce any human tissue specimen \n        for medical research or education unless--\n                    (A) a tissue bank license is in effect for the \n                entity introducing the human tissue specimen into \n                interstate commerce;\n                    (B) each package of the human tissue specimen is--\n                            (i) labeled with the proper name of the \n                        human tissue specimen contained in the package;\n                            (ii) the name, address, and applicable \n                        license number of the source tissue bank of the \n                        human tissue specimen;\n                            (iii) unique donor identifier, tissue type, \n                        cause of death, serological test results and \n                        any known infectious disease agents;\n                            (iv) a statement about the mandatory use of \n                        personal protective equipment and universal \n                        precautions when handling human tissue; and\n                            (v) labeled ``not for transplantation''; \n                        and\n                    (C) each package of the human tissue specimen is \n                wrapped and packaged in such a manner that--\n                            (i) mitigates potential contamination and \n                        cross contamination;\n                            (ii) mitigates potential safety hazards;\n                            (iii) sealed to prevent leakage; and\n                            (iv) ensures the integrity of the tissue.\n            (2) Procedures established.--\n                    (A) In general.--The Secretary of Health and Human \n                Services shall establish, by rule, requirements for the \n                approval, suspension, and revocation of non-transplant \n                tissue bank licenses.\n                    (B) Approval.--The Secretary shall approve a non-\n                transplant tissue bank license application--\n                            (i) on the basis of a demonstration that--\n                                    (I) the human tissue specimen that \n                                is the subject of the application is \n                                legally donated, properly screened for \n                                communicable disease agents, properly \n                                labeled, transported, stored and used \n                                according to the donor's donation \n                                authorization; and\n                                    (II) the facility in which the \n                                human tissue specimen is donated, \n                                recovered, processed, packed, or held \n                                meets standards designed to assure that \n                                the human tissue specimen does not pose \n                                a communicable disease risk to the \n                                general public and/or unknown \n                                communicable disease risk to; and\n                            (ii) if the applicant (or other appropriate \n                        person) consents to the inspection of the \n                        facility that is the subject of the \n                        application, in accordance with subsection (c) \n                        of this section.\n            (3) Requirements for exemption.--The Secretary shall \n        prescribe requirements under which a human tissue specimen \n        shall be exempt from the requirements of paragraph (1).\n    (b) Falsely Labeling or Marking Package or Container; Altering \nLabel or Mark.--No person shall falsely label or mark any package or \ncontainer of any human tissue specimen or alter any label or mark on \nthe package or container of the biological product so as to falsify the \nlabel or mark.\n    (c) Inspection of Establishment for Propagation and Preparation.--\n            (1) In general.--Any officer, agent, or employee of the \n        Department of Health and Human Services, authorized by the \n        Secretary for the purpose, may during all reasonable hours \n        enter and inspect any establishment for the propagation or \n        recovery and preparation of any human tissue specimen.\n            (2) Inspection by nationally recognized accrediting \n        bodies.--Any authorized agent of a nationally recognized \n        accrediting body authorized by the Secretary for the purpose, \n        may during all reasonable hours enter and inspect any \n        establishment for the propagation or recovery and preparation \n        of any human tissue specimen.\n            (3) Rule of construction.--Nothing in this subsection or \n        Act limits any existing authority of the Attorney General, any \n        State Attorney General or local law enforcement to enter and \n        inspect any establishment for the propagation or recovery and \n        preparation of any human tissue.\n    (d) Recall of Specimen Presenting Imminent Hazard; Violations.--\n            (1) Recall.--Upon a determination that a human tissue \n        specimen or collection of specimens licensed under this section \n        presents an imminent or substantial hazard to the public \n        health, the Secretary shall issue an order immediately ordering \n        the recall of such batch, lot, or other quantity of such \n        product. An order under this paragraph shall be issued in \n        accordance with section 554 of title 5.\n            (2) Violations.--Any violation of paragraph (1) shall \n        subject the violator to a civil penalty of up to $10,000 per \n        day of violation. The amount of a civil penalty under this \n        paragraph shall, effective December 1 of each year beginning 1 \n        year after the effective date of this paragraph, be increased \n        by the percent change in the Consumer Price Index for the base \n        quarter of such year over the Consumer Price Index for the base \n        quarter of the preceding year, adjusted to the nearest \\1/10\\ \n        of 1 percent. For purposes of this paragraph, the term ``base \n        quarter'', as used with respect to a year, means the calendar \n        quarter ending on September 30 of such year and the price index \n        for a base quarter is the arithmetical mean of such index for \n        the 3 months comprising such quarter.\n    (e) Penalties for Offenses.--Whoever violates any of the provisions \nof this section shall be imprisoned not more than 1 year, or fined not \nmore than $500, or both. Section 3571 of title 18, United States Code \nshall not apply to an offense under this subsection.\n    (f) Construction With Other Laws.--Nothing contained in this Act \nshall be construed as in any way affecting, modifying, repealing, or \nsuperseding under any existing provisions under current Federal law.\n    (g) Human Tissue Specimen Defined.--In this section, the term \n``non-transplant tissue specimen'' means legally donated anatomical \nsegments, cells, collection of cells, bodily fluids, or the complete \nbody that are recovered for medical research and education. The term \ndoes not include anything that would qualify as a biological product \nunder the Public Health Service Act."
}